News

The current paradigm of injectable drug delivery has stagnated since the early 2000s. Despite recent innovations, like the launch in Europe of the first electromechanical reusable and connected auto-injector (UCB’s CIMZIA ava Connect® in early 2021), almost all new biologic drugs are launched with specific and undifferentiated self-injection options: a spring-based mechanical auto-injector (e.g., SHL’s Molly® and Ypsomed’s Ypsomate®) and a prefilled syringe, often with attached safety device, (e.g., Becton Dickinson’s UltraSafe Passive™). This now-common set of options only serves two classes of patients well. 

In the consumer tech world, iterations happen very fast,  though most inventions are not ‘one and done’ masterpieces: the Dyson cyclone vacuum cleaner made 5,127 prototypes. In the medical device world, development takes longer because of the appropriate and necessary regulations and need for safety.  Using an agile approach, but with safety and reliability in mind, Portal has made tremendous technological advancement in the development of a next-generation needle-free injector through multiple iterations and prototypes.

Twelve years ago Jody started getting unexplained pain, swelling and redness in her eyes after having her first child. Shortly after, she was diagnosed with Scleritis, a serious eye disease that is often associated with an underlying autoimmune disorder. Fast forward to today, Jody has started taking weekly injections to ease her symptoms. We sat down with Jody to hear about her first at home injection.

Cambridge, MA, September 28, 2021 - Cambridge, MA – Portal Instruments, developer of the Prime needle-free drug delivery platform, announced that a new clinical study demonstrating patient preference for Prime needle-free injections was published this month in the journal Drug Delivery.

Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th.

August is National Psoriasis Awareness Month. To bring awareness to the illness and injection challenges, we spoke with Grace Vasher and learned about her personal journey with Psoriasis. Grace is a nineteen year old college student studying elementary education.

Many men watching their significant others go through infertility treatment feel hopeless. Listen to this patient tell a story about what one man does to help cope with the stress of administering injections.

Many undergraduate students get the opportunity during their college years to complete a summer internship. Others participate in a Co-Op; a 6-month long internship where students are able to fully immerse themselves in a full-time employment position to better understand their place in the workspace. This allows students to further explore desired fields before graduation. This year Portal Instruments had three Co-Op students working in departments from software engineering to marketing and strategy.

The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹ We sat down to learn from Joelle Jacoski about the drug delivery challenges of taking GAHT.